• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Ultane and Ultane NovaPlus (Sevoflurane) Volatile Liquid for Inhalation

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – August 2012

Summary View

 

WARNINGS

  • e.g., patients with congenital Long QT Syndrome or patients taking drugs that can prolong the QT interval).
 

 

-
-